The COVID-19 vaccine in 2025 is primarily offered to people aged 75 and over, residents in care homes for older adults, and individuals aged 6 months and older with weakened immune systems due to health conditions or treatments. This includes people with conditions such as blood cancer, organ transplants, HIV, genetic immune disorders, or those on immunosuppressive therapies. The vaccine is aimed at protecting those at higher risk of severe illness from COVID-19. Additionally, the FDA authorizes updated COVID-19 vaccines mainly for people 65 and older or younger individuals with health risks that increase the chance of severe disease. In summary, the key eligibility groups for the COVID-19 vaccine in 2025 are:
- Adults aged 75 years and older
- Residents in care homes for older adults
- Individuals aged 6 months and older with a weakened immune system or certain high-risk health conditions
- People 65 and older or younger high-risk individuals as per FDA guidelines
You do not need to be in these groups to get a vaccine routinely, as the focus has shifted to those most vulnerable due to age or medical conditions.
